Work to recruit patients to research trials highlighted

The trust has been recognised for its work around recruiting more people into pioneering research trials.

The 2017/18 NIHR Research Activity League Table have been published today by the National Institute for Health Research (NIHR) Clinical Research Network (CRN).

The league table highlights the extent of NHS research taking place in England, and the number of participants being recruited into studies.

Trusts and Clinical Commissioning Groups (CCGs) across the North East have also seen a surge in the number of people participating in research trials with a total of 42,450 people getting involved in 1,630 programmes a rise of 23% from last year.

The trust saw one of the biggest increases in the region, with participation figures almost doubling from 839 to 1,619.

Beth Pickering, the trust’s research and development facilitator, said: “We are delighted at the number of patients we have recruited over the last year – it has been one of our most successful years on record.

“It’s testament to the commitment and dedication our research and development team across the trust have shown.

“Thank you to everyone involved, as well as to patients who have volunteered to take part. Research trials are our way of making improvements so that we are able to give the very best care to patients.”

An example of a recent success the trust achieved came last month when the research and development team worked together to support the critical care team to recruit 152 patients to a drug allergy study in the main operating theatres.

Many patients report drug allergies during their pre-operative anaesthetic assessment. The nature of these reactions are interpreted by the anaesthetist on the day of surgery which influences pharmacological management during the peri-operative period.

The trial is designed to evaluate patient-reported and documented allergy to drugs relevant to anaesthesia and to learn more about anaesthetists’ knowledge and attitudes to allergy.

Leave a comment

comments powered by Disqus